Interleukin-17 family cytokines in protective immunity against infections: role of hematopoietic cell-derived and non-hematopoietic cell-derived interleukin-17s

Microbiology and Immunology

Volumn 62, Issue 1, 2018, Pages 1-13

  Matsuzaki, Goro ^a   Umemura, Masayuki ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

infection; interleukin 17; interleukin 17 receptor

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17B; INTERLEUKIN 17C; INTERLEUKIN 17F; INTERLEUKIN 25; INTERLEUKIN 27; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; CYTOKINE; IL17A PROTEIN, HUMAN; IL25 PROTEIN, HUMAN; INTERLEUKIN 17 RECEPTOR;

CANDIDIASIS; CHAGAS DISEASE; CRYPTOCOCCOSIS; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; HEMATOPOIETIC CELL; HERPES SIMPLEX; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFECTION; INFLUENZA; INTESTINE INFECTION; KERATITIS; LEISHMANIASIS; LISTERIOSIS; LUNG INFECTION; LUNG TUBERCULOSIS; NEMATODIASIS; NONHUMAN; NOSE INFECTION; PERIODONTITIS; PERITONITIS; PERTUSSIS; PLAGUE; PNEUMOCYSTOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SKIN INFECTION; STAPHYLOCOCCUS INFECTION; TOXOPLASMOSIS; TUBERCULOSIS; VACCINIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINE; CLASSIFICATION; EPITHELIUM CELL; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROBIOLOGY; NATURAL KILLER T CELL; NEUTROPHIL; TH17 CELL; TH2 CELL; VIROLOGY;

ANTIMICROBIAL CATIONIC PEPTIDES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOKINES; EPITHELIAL CELLS; HUMANS; INFECTION; INFLAMMATION; INTERLEUKIN-17; NATURAL KILLER T-CELLS; NEUTROPHILS; RECEPTORS, INTERLEUKIN-17; TH17 CELLS; TH2 CELLS;

EID: 85040347426     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/1348-0421.12560     Document Type: Review

References (105)

1. Moseley T.A., Haudenschild D.R., Rose L., Reddi A.H. (2003) Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 14: 155–74.
2. Amatya N., Garg A.V., Gaffen S.L. (2017) IL-17 Signaling: The yin and the yang. Trends Immunol 38: 310–22.
3. Gaffen S.L. (2010) Structure and signaling in the IL-17 receptor superfamily. Nat Rev Immunol 9: 1–24.
4. Korn T., Bettelli E., Oukka M., Kuchroo V.K. (2009) IL-17 and Th17 cells. Annu Rev Immunol 27: 485–517.
5. Matsuzaki G., Umemura M. (2007) Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol 51: 1139–47.
6. Singh R.P., Hasan S., Sharma S., Nagra S., Yamaguchi D.T., Wong D.T.W., Hahn B.H., Hossain A. (2014) Th17 cells in inflammation and autoimmunity. Autoimmun Rev 13: 1174–81.
7. Rutz S., Eidenschenk C., Ouyang W. (2013) IL-22, not simply a Th17 cytokine. Immunol Rev 252: 116–32.
8. Annunziato F., Romagnani C., Romagnani S. (2015) The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol 135: 626–35.
9. Papotto P.H., Ribot J.C., Silva-Santos B. (2017) IL-17 + γδ T cells as kick-starters of inflammation. Nat Immunol 18: 604–11.
10. Xu M., Dong C. (2017) IL-25 in allergic inflammation. Immunol Rev 278: 185–91.
11. Ramirez-Carrozzi V., Sambandam A., Luis E., Lin Z., Jeet S., Lesch J., Hackney J., Kim J., Zhou M., Lai J., Modrusan Z., Sai T., Lee W., Xu M., Caplazi P., Diehl L., de Voss J., Balazs M., Gonzalez L., Singh H., Ouyang W., Pappu R. (2011) IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat Immunol 12: 1159–66.
12. Song X., Zhu S., Shi P., Liu Y., Shi Y., Levin S.D., Qian Y. (2011) IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nat Immunol 12: 1151–8.
13. Reynolds J.M., Lee Y.H., Shi Y., Wang X., Angkasekwinai P., Nallaparaju K.C., Flaherty S., Chang S.H., Watarai H., Dong C. (2015) Interleukin-17B antagonizesi nterleukin-25-mediated mucosal inflammation. Immunity 42: 692–703.
14. Saddawi-Konefka R., Seelige R., Gross E.T.E., Levy E., Searles S.C., Washington A., Santosa E.K., Liu B., O'Sullivan T.E., Harismendy O., Bui J.D. (2016) Nrf2 induces IL-17D to mediate tumor and virus surveillance. Cell Rep 16: 2348–58.
15. Gerbe F., Sidot E., Smyth D.J., Ohmoto M., Matsumoto I., Dardalhon V., Garnier L., Pouzolles M., Brulin B., Bruschi M., Harcus Y., Zimmermann V.S., Taylor N., Maizels R.M., Jay P. (2016) Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites. Nature 529: 226–30.
16. von Moltke J., Ji M, Liang H.-E., Locksley R.M. (2015) Tuft-cell-derived IL-25 regulates an intestinal ILC2–epithelial response circuit. Nature 529: 221–5.
17. Ishigame H., Kakuta S., Nagai T., Kadoki M., Nambu A., Komiyama Y., Fujikado N., Tanahashi Y., Akitsu A., Kotaki H., Sudo K., Nakae S., Sasakawa C., Iwakura Y. (2009) Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30: 108–19.
18. Ye P., Rodriguez F.H., Kanaly S., Stocking K.L., Schurr J., Schwarzenberger P., Oliver P., Huang W., Zhang P., Zhang J., Shellito J.E., Bagby G.J., Nelson S., Charrier K., Peschon J.J., Kolls J.K. (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194: 519–28.
19. Happel K.I., Zheng M., Young E., Quinton L.J., Lockhart E., Ramsay A.J., Shellito J.E., Schurr J.R., Bagby G.J., Steve N., Kolls J.K. (2003) Roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae Infection. J Immunol 170: 4432–6.
20. Tanaka S., Yoshimoto T., Naka T., Nakae S., Iwakura Y.-I., Cua D., Kubo M. (2009) Natural occurring IL-17 producing T cells regulate the Iinitial phase of neutrophil mediated airway rResponses. J Immunol 183: 7523–30.
21. Price A.E., Reinhardt R.L., Liang H.E., Locksley R.M. (2012) Marking and quantifying IL-17A-producing cells in vivo. PLoS ONE 7: e39750.
22. hi monocyte crosstalk promotes Klebsiella pneumoniae clearance. Cell 165: 679–89.
23. Cheng P., Liu T., Zhou W.-Y., Zhuang Y., Peng L., Zhang J., Yin Z.-N., Mao X.-H., Guo G., Shi Y., Zou Q.-M. (2012) Role of γδ T cells in host response against Staphylococcus aureus-induced pneumonia. BMC Immunol 13: 38.
24. Cho J.S., Pietras E.M., Garcia N.C., Ramos R.I., Farzam D.M., Monroe H.R., Magorien E.J., Blauvelt A., Kolls J.K., Cheung A.L., Cheng G., Modlin R.L., Miller L.S. (2010) IL-17 is essential for host defense against cutaneous Staphyloccocus aureus infection in mice. J Clin Invest 120: 1762–73.
25. Murphy AG., O'Keeffe K.M., Lalor S.J., Maher B.M., Mills K.H.G., McLoughlin R.M. (2014) Staphylococcus aureus infection of mice expands a population of memory γδ T cells that are protective against subsequent infection. J Immunol 192: 3697–708.
26. McAllister F., Henry A., Kreindler J.L., Dubin P.J., Ulrich L., Steele C., Finder J.D., Pilewski J.M.K., Carreno B.M., Goldman S.J., Pirhonen J., Kolls J.K. (2005) Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: Implications for airway inflammation in cystic fibrosis. J Immunol 175: 404–12.
27. Bayes H.K., Ritchie N.D., Evans T.J. (2016) IL-17 is required for control of chronic lung infection caused by Pseudomonas aeruginosa. Infect Immun 84: 3507–16.
28. Chen X., Howard O.M.Z., Oppenheim J.J. (2007) Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells. J Immunol 178: 6123–9.
29. Ross P.J., Sutton C.E., Higgins S., Allen A.C., Walsh K., Misiak A., Labelle E.C., McLoughlin R.E., Mills K.H.G. (2013) Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: Towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog 9: e1003264.
30. Misiak A., Wilk M.M., Raverdeau M., Mills K.H.G. (2017) IL-17-Producing innate and pathogen-specific tissue resident memory γδ T cells expand in the lungs of Bordetella pertussis-infected mice. J Immunol 198: 363–74.
31. Shibata K., Yamada H., Hara H., Kishihara K., Yoshikai Y. (2007) Resident Vδ1+ γδ T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol 178: 4466–72.
32. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., Weaver C.T. (2006) Transforming growth factor-β induces development of the TH17 lineage. Nature 441: 231–4.
33. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., Abbas A.R., Modrusan Z., Ghilardi N., de Sauvage F.J., Ouyang W. (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14: 282–9.
34. Bi Y., Zhou J., Yang H., Wang X., Zhang X., Wang Q., Wu X., Han Y., Song Y., Tan Y., Du Z., Yang H., Zhou D., Cui Y., Zhou L., Yan Y., Zhang P., Guo Z., Wang X., Liu G., Yang R. (2014) IL-17A produced by neutrophils protects against pneumonic plague through orchestrating IFN-γ-activated macrophage programming. J Immunol 192: 704–13.
35. Caruso R., Fina D., Paoluzi O.A., Blanco G.D.V., Stolfi C., Rizzo A., Caprioli F., Sarra M., Andrei F., Fantini M.C., MacDonald T.T., Pallone F., Monteleone G. (2008) IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur J Immunol 38: 470–8.
36. Dixon B.R.E.A., Radin J.N., Piazuelo M.B., Contreras D.C., Algood H.M.S. (2016) IL-17A and IL-22 induce expression of antimicrobials in gastrointestinal epithelial cells and may contribute to epithelial cell defense against Helicobacter pylori. PLoS ONE 11: 1–19.
37. St. Leger A.J., Desai J.V., Drummond R.A., Kugadas A., Almaghrabi F., Silver P., Raychaudhuri K., Gadjeva M., Iwakura Y., Lionakis M.S., Caspi R.R. An ocular commensal protects against corneal infection by driving an interleukin-17 response from mucosal γδ T cells. Immunity 47: 148–58.
38. Flierl M.A., Rittirsch D., Gao H., Hoesel L.M., Nadeau B.A., Day D.E., Zetoune F.S., Sarma J.V., Huber-Lang M.S., Ferrara J.L.M., Ward P.A. (2008) Adverse functions of IL-17A in experimental sepsis. FASEB J 22: 2198–205.
39. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235–8.
40. Yu J.J., Ruddy M.J., Wong G.C., Sfintescu C., Baker P.J., Smith J.B., Evans R.T., Gaffen S.L. (2007) An essential role for IL-17 in preventing pathogen­initiated bone destruction: Recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109: 3794–802.
41. Azman R., Lappin D.F., MacPherson A., Riggio M., Robertson D., Hodge P., Ramage G., Culshaw S., Preshaw P.M., Taylor J., Nile C. (2014) Clinical associations between IL-17 family cytokines and periodontitis and potential differential roles for IL-17A and IL-17E in periodontal immunity. Inflamm Res 63: 1001–12.
42. Cai S., Batra S., Langohr I., Iwakura Y., Jeyaseelan S. (2016) IFN-γ induction by neutrophil-derived IL-17A homodimer augments pulmonary antibacterial defense. Mucosal Immunol 9: 718–29.
43. Taylor P.R., Leal S.M., Sun Y., Pearlman E. (2014) Aspergillus and Fusarium corneal infections are regulated by Th17 cells and IL-17-producing neutrophils. J Immunol 192: 3319–27.
44. Hamada S., U.memura M., Shiono T., Tanaka K., Yahagi A., Begum M.D., Oshiro K., Okamoto Y., Watanabe H., Kawakami K., Roark C., Born W.K., O'Brien R., Ikuta K., Ishikawa H., Nakae S., Iwakura Y., Ohta T., Matsuzaki G. IL-17A produced by γδ T cells plays a critical role in innate immunity against Listeria monocytogenes infection in the liver. J Immunol 181: 3456–63.
45. Hamada S., Umemura M., Shiono T., Hara H., Kishihara K., Tanaka K., Mayuzumi H., Ohta T., Matsuzaki G. (2008) Importance of murine Vδ1 γδ T cells expressing interferon-γ and interleukin-17A in innate protection against Listeria monocytogenes infection. Immunology 125: 170–7.
46. Okita Y., Shiono T., Yahagi A., Hamada S., Umemura M., Matsuzaki G. (2016) Interleukin-22-induced antimicrobial phospholipase A2 group IIA mediates protective innate immunity of nonhematopoietic cells against Listeria monocytogenes. Infect Immun 84: 573–9.
47. Xu S., Han Y., Xu X., Bao Y., Zhang M., Cao X. (2010) IL-17A-producing γδT cells promote CTL responses against Listeria monocytogenes infection by enhancing dendritic cell cross-presentation. J Immunol 185: 5879–87.
48. Ryan-Payseur B., Frencher J., Shen L., Chen C.Y., Huang D., Chen Z.W. (2012) Multieffector-functional immune responses of HMBPP-specific Vγ2Vδ2 T cells in nonhuman primates inoculated with Listeria monocytogenes actA prfA*. J Immunol 189: 1285–93.
49. Lockhart E., Green A.M., Flynn J.L. (2006) IL-17 production is dominated by γδ T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 177: 4662–9.
50. Umemura M., Yahagi A., Hamada S., Begum M.D., Watanabe H., Kawakami K., Suda T., Sudo K., Nakae S., Iwakura Y., Matsuzaki G. (2007) IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis Bacille Calmette–Guerin infection. J Immunol 178: 3786–96.
51. Okamoto Yoshida Y., Umemura M., Yahagi A., O'Brien R.L., Ikuta K., Kishihara K., Hara H., Nakae S., Iwakura Y., Matsuzaki G. (2010) Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J Immunol 184: 4414–22.
52. Freches D., Korf H., Denis O., Havaux X., Huygen K., Romano M. (2013) Mice genetically inactivated in interleukin-17A receptor are defective in long-term control of Mycobacterium tuberculosis infection. Immunology 140: 220–31.
53. Umemura M., Okamoto-Yoshida Y., Yahagi A., Touyama S., Nakae S., Iwakura Y., Matsuzaki G. (2016) Involvement of IL-17A-producing TCR γδ T cells in late protective immunity against pulmonary Mycobacterium tuberculosis infection. Immunity Inflamm Dis 4: 401–12.
54. Gopal R., Monin L., Slight S., Uche U., Blanchard E., Junecko B.A.F., Ramos-Payan R., Stallings C.L., Reinhart T.A., Kolls J.K., Kaushal D., Nagarajan U., Rangel-Moreno J., Khader S.A. (2014) Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection. PLoS Pathog 10: e1004099.
55. Segueni N., Tritto E., Bourigault M.-L., Rose S., Erard F., Le Bert M., Jacobs M., Di Padova F., Stiehl D.P., Moulin P., Brees D., Chibout S.-D., Ryffel B., Kammüller M., Quesniaux V.F. (2016) Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization. Sci Rep 6: 36923.
56. Khader S.A., Guglani L., Rangel-Moreno J., Gopal R., Fallert Junecko BA., Fountain J.J., Martino C., Pearl J.E., Tighe M., Lin Y.-Y., Slight S., Kolls J.K., Reinhart T.A., Randall T.D., Cooper A.M. (2011) IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung. J Immunol 187: 5402–7.
57. Khader S.A., Bell G.K., Pearl J.E., Fountain J.J., Rangel-Moreno J., Cilley G.E., Shen F., Eaton S.M., Sheri M., Gaffen S.L., Swain S.L., Locksley R.M., Haynes L., Randall T.D., Cooper A.M. (2007) IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8: 369–77.
58. Fukui M., Shinjo K., Umemura M., Shigeno S., Harakuni T., Arakawa T., Matsuzaki G. (2015) Enhanced effect of BCG vaccine against pulmonary Mycobacterium tuberculosis infection in mice with lung Th17 response to mycobacterial heparin-binding hemagglutinin adhesin antigen. Microbiol Immunol 59: 735–43.
59. Cruz A., Fraga A.G., Fountain J.J., Rangel-Moreno J., Torrado E., Saraiva M., Pereira D.R., Randall T.D., Pedrosa J., Cooper A.M., Castro A.G. (2010) Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J Exp Med 207: 1609–16.
60. Okada S., Markle J.G., Deenick E.K., Mele F., Averbuch D., Lagos M., Alzahran M., Al-Muhsen S., Halwani R., Ma C.S., Wong N., Soudais C., Henderson L.A., Marzouqa H., Shamma J., Gonzalez M., Martinez-Barricarte R., Okada C., Avery D.T., Latorre D., Deswarte C., Jabot-Hanin F., Torrado E., Fountain J., Belkadi A., Itan Y., Boisson B., Migaud M., Lindestam Arlehamn C.S., Sette A., Breton S., McCluskey J., Rossjohn J., de Villartay J.-P., Moshous D., Hambleton S., Latou S., Arkwright P.D., Picard C., Lantz O., Engelhard D., Kobayashi M., Abel L., Cooper A.M., Notarangelo L.D., Boisson-Dupuis S., Puel A., Sallusto F., Bustamante J., Tangye S.G.T., Casanova J.-L. (2015) Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science 349: 606–14.
61. Scriba T.J., Kalsdorf B., Abrahams D.-A., Isaacs F., Hofmeister J., Black G., Hassan H.Y., Wilkinson R.J., Walzl G., Gelderbloem S.J., Mahomed H., Hussey G.D., Hanekom W.A. (2008) Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 180: 1962–70.
62. Lin Y., Ritchea S., Logar A., Slight S., Messmer M., Rangel-Moreno J., Guglani L., Alcorn J.F., Strawbridge H., Park S.M., Sang M., Onishi R., Nyugen N., Walter M.J., Pociask D., Randall T.D., Gaffen S.L., Iwakura Y., Kolls J.K., Khader S.A. (2009) Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 31: 799–810.
63. Bai H., Cheng J., Gao X., Joyee A.G., Fan Y., Wang S., Jiao L., Yao Z., Yang X. (2009) IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J Immunol 183: 5886–95.
64. Andrew D.W., Cochrane M., Schripsema J.H., Ramsey K.H., Dando S.J., O'Meara C.P., Timms P., Beagley K.W. (2013) The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization. PLoS ONE 8: 1–14.
65. Wu Q., Martin R.J., Rino J.G., Breed R., Torres R.M., Chu H.W. (2007) IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect 9: 78–86.
66. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., Sallusto F. (2007) Napollitani G. Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells. Nat Immunol 8: 639–46.
67. LeibundGut-Landmann S., Groß O., Robinson M.J., Osorio F., Slack E.C., Tsoni S.V., Schweighoffer E., Tybulewicz V., Brown G.D., Ruland J., Reis e Sousa C. (2007) Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8: 630–8.
68. Saijo S., Ikeda S., Yamabe K., Kakuta S., Ishigame H., Akitsu A., Fujikado N., Kusaka T., Kubo S., Chung S.-H., Komatsu R., Miura N., Adachi Y., Ohno N., Shibuya K., Yamamoto N., Kawakami K., Yamasaki S., Saito T. (2010) Dectin-2 recognition of α-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 32: 681–91.
69. Huang W., Na L., Fidel P.L., Schwarzenberger P. (2004) Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190: 624–31.
70. Conti H.R., Peterson A.C., Brane L., Huppler A.R., Hernández-Santos N., Whibley N., Garg A., Simpson-Abelson M.R., Gibson G.A., Mamo A.J., Osborne L.C., Bishu S., Ghilardi N., Siebenlist U., Watkins S.C., Artis D., McGeachy M.J., Gaffen S.L. (2013) Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections. J Exp Med 211: 2075–84.
71. Trautwein-Weidner K., Gladiator A., Nur S., Diethelm P., LeibundGut-Landmann S. (2014) IL-17-mediated antifungal defense in the oral mucosa is independent of neutrophils. Mucosal Immunol 8: 221–31.
72. Conti H.R., Bruno V.M., Childs E.E., Daugherty S., Hunter J.P., Mengesha B.G., Saevig D.L., Hendricks M.R., Coleman B.M., Brane L., Solis N., Cruz J.A., Verma A.H., Garg A.V., Hise A.G., Richardson J.P., Naglik J.R., Filler S.G., Kolls J.K., Sinha S., Gaffen S.L. (2016) IL-17 receptor signaling in oral epithelial cells is critical for protection against oropharyngeal candidiasis. Cell Host Microbe 20: 606–17.
73. Puel A., Cypowyj S., Bustamante J., Wright J.F., Liu L., Lim H.K., Migaud M., Israel L., Chrabieh M., Audry M., Gumbleton M., Toulon A., Bodemer C., El-Baghdadi J., Whitters M., Paradis T., Brooks J., Collins M., Wolfman N.M., Al-Muhsen S., Galicchio M., Abel L., Picard C., Casanova, J.-L. (2011) Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332: 65–8.
74. Lévy R., Okada S., Béziat V., Moriya K., Liu C., Chai L.Y.A., Migaud M., Hauck F., Al Ali A., Cyrus C., Vatte C., Patiroglu T., Unal E., Ferneiny M., Hyakuna N., Nepesov S., Oleastro M., Ikinciogullari A., Dogu F., Asano T., Ohara O., Yun L., Della Mina E., Bronnimann D., Itan Y., Gothe F., Bustamante J., Boisson-Dupuis S., Tahuil N., Aytekin C., Salhi A., Al Muhsen S., Kobayashi M., Toubiana J., Abel L., Li X., Camcioglu Y., Celmeli F., Klein C., AlKhater S.A., Casanova J.-L., Puel A. (2016) Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci USA 113: E8277–85.
75. LeibundGut-Landmann S., Gross O., Robinson J.W., Osorio F., Slack E.C., Tsoni S.V., Schweighoffer E., Tybluewicz V., Brown G.D., Ruland J., Reis e Sousa C. (2007) Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8: 630–8.
76. Erik-Oliver Glocker E.-O., Hennigs A., Nabavi M., Schäffer A.A., Woellner C., Salzer U., Pfeife D., Veelken H., Warnatz K., Tahami F., Jama S., Manguiat A., Rezaei N., Amirzargar A.A., Pleban A., Hannesschläger N., Gross O., Ruland J., Grimbacher B. (2009) A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 361: 1725–35.
77. Baeten D., Sieper J., Braun J., Baraliakos X., Dougados M., Emery P., Deodhar A., Porter B., Martin R., Andersson M., Mpofu S., Richards H.B. (2015) Secukinumab, an interleukin-17a inhibitor, in ankylosing spondylitis. N Engl J Med 373: 2534–48.
78. Murdock B.J., Huffnagle G.B., Olszewski M.A., Osterholzer J.J. (2014) Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production. Infect Immun 82: 937–48.
79. Kleinschek M.A., Muller U., Brodie S.J., Stenzel W., Kohler G., Blumenschein W.M., Straubinger R.K., McClanahan T., Kastelein R.A., Alber G. (2006) IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J Immunol 176: 1098–106.
80. Rudner X.L., Happel K.I., Young E.A., Shellito J.E. (2007) Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 75: 3055–61.
81. Guerra E.S., Lee C.K., Specht C.A., Yadav B., Huang H., Akalin A., Huh J.R., Mueller C., Levitz S.M. (2017) Central role of IL-23 and IL-17 producing eosinophils as immunomodulatory effector cells in acute pulmonary aspergillosis and allergic asthma. PLoS Pathog 13: e1006175.
82. Erdmann H., Roßnagel C., Böhme J., Iwakura Y., Jacobs T., Schaible U.E., Hölscher C. (2013) IL-17A promotes macrophage effector mechanisms against Trypanosoma cruzi by trapping parasites in the endolysosomal compartment. Immunobiology 218: 910–23.
83. Bermejo D.A., Jackson S.W., Gorosito-Serran M., Acosta-Rodriguez E.V., Amezcua-Vesely M.C., Sather B.D., Singh A.K., Khim S., Mucci J., Liggitt D., Campetella O., Oukka M., Gruppi A., Rawlings D.J. (2013) Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells. Nat Immunol 14: 514–22.
84. Suryawanshi A., Cao Z., Sampson J.F., Panjwani N. (2015) IL-17A–mediated protection against Acanthamoeba keratitis. J Immunol 194: 650–63.
85. Boaventura V.S., Santos C.S., Cardoso C.R., De Andrade J., Dos Santos W.L.C., Clarêncio J., Silva J.S., Borges V.M., Barral-Netto M., Brodskyn C.I., Barral A. (2010) Human mucosal leishmaniasis: Neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines. Eur J Immunol 40: 2830–6.
86. Hartley M.A., Bourreau E., Rossi M., Castiglioni P., Eren R.O., Prevel F., Couppié P., Hickerson S.M., Launois P., Beverley S.M., Ronet C., Fasel N. (2016) Leishmania virus-dependent metastatic leishmaniasis is prevented by blocking IL-17A. PLoS Pathog 12: e1005852.
87. Kelly M.N., Kolls J.K., Happel K., Joseph D., Schwarzenberger P., Combe C., Moretto M., Khan I.A., Schwartzman J.D. (2005) Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect Immun 73: 617–21.
88. Guiton R., Vasseur V., Charron S., Arias M.T., Van Langendonck N., Buzoni-gatel D., Ryffel B., Dimier-Poisson I. (2017) Interleukin 17 receptor signaling is deleterious during Toxoplasma gondii infection in susceptible BL6 mice. J Infect Dis 202: 427–35.
89. Zheng L., Hu Y., Wang Y., Huang X., Xu Y., Shen Y., Cao J. (2017) Recruitment of neutrophils mediated by Vγ2 γδ T cells deteriorates liver fibrosis induced by Schistosoma japonicum infection in C57BL/6 mice. Infect Immun 85: e01020–16.
90. Rutitzky L.I., Lopes da Rosa J.R., Stadecker M.J. (2005) Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J Immunol 175: 3920–6.
91. Rutitzky L.I., Bazzone L., Shainheit M.G., Joyce-Shaikh B., Cua D.J., Stadecker M.J. (2008) IL-23 is required for the development of severe egg-induced immunopathology in schistosomiasis and for lesional expression of IL-17. J Immunol 180: 2486–95.
92. Mckinstry K.K., Strutt T.M., Buck A., Curtis D., Dibble J.P., Huston G., Sell S., Dutton R.W., Swain S.L. (2009) IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol 182: 7353–63.
93. Wang X., Chan C.C.S., Yang M., Deng J., Poon V.K.M., Leung V.H.C., Zhou J., Yuen K.Y., Zheng B.-J., Lu L. (2011) A critical role of IL-17 in modulating the B-cell response during H5N1 influenza virus infection. Cell Mol Immunol 8: 462–8.
94. Wang X., Ma K., Chen M., Ko K.H., Zheng B.J., Lu L. (2016) IL-17A promotes pulmonary B-1a cell differentiation via induction of Blimp-1 expression during influenza virus infection. PLoS Pathog 12: e1005367.
95. Crowe C.R., Chen K., Pociask D.A., Alcorn J.F., Krivich C., Enelow R.I., Ross T.E., Witztum J.L., Kolls J.K. (2009) Critical role of IL-17RA in immunopathology of influenza infection. J Immunol 183: 5301–10.
96. Suryawanshi A., Veiga-Parga T., Rajasagi N.K., Reddy P.B.J., Sehrawat S., Sharma S., Rouse B.T. (2011) Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. J Immunol 187: 1919–30.
97. Reynolds J.M., Martinez G.J., Nallaparaju K.C., Chang S.H., Wang Y.-H., Dong C. (2012) Regulation of intestinal inflammation and barrier function by IL-17C. J Immunol 189: 4226–30.
98. Conti H.R., Whibley N., Coleman B.M., Garg A.V., Jaycox J.R., Gaffen S.L. (2015) Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis. PLoS ONE 10: e0122807.
99. Huang J., Meng S., Hong S., Lin X., Jin W., Dong C. (2016) IL-17C is required for lethal inflammation during systemic fungal infection. Cell Mol Immunol 13: 474–83.
100. Roth S., Simanski M., Rademacher F., Schröder L., Harder J. (2014) The pattern recognition receptor NOD2 mediates Staphylococcus aureus-induced IL-17C expression in keratinocytes. J Invest Med 134: 374–80.
101. Tanaka S., Nagashima H., Cruz M., Uhcida T., Uotani T., Jiménze Abreu J.A., Mahachai V., VIlaichone R.K., Ratanchu-ek T., Tshering L., Graham D.Y., Yamaoka Y. (2017) Interleukin-17C in human Helicobacter pylori gastritis. Infect Immune 85: e00389–17.
102. Wolf L., Sapich S., Honecker A., Jungnickel C., Seiler F., Bischoff M., Wonnenberg B., Herr C., Schneider-Daum N., Lehr C.-M., Bals R., Beisswenger C. (2016) IL-17A-mediated expression of epithelial IL-17C promotes inflammation during Pseudomonas aeruginosa pneumonia. Am J Physiol Lung Cell Mol Physiol 311: L1015–22.
103. Peng T., Chanthaphavong S., Sun S., Trigilio A., Phasouk K., Jin L., Layton E.D., Li A.Z., Correnti C.E., De an der Schueren W., Vazquez J., O'Day D.R., Glass I.A., Knipe D.M., Wald A., Corey L., Zhu J. (2017) Keratinocytes produce IL-17c to protect peripheral nervous systems during human HSV-2 reactivation. J Exp Med 214: 2315–29.
104. Seelige R., Washington Jr. A., Bui J.D. (2017) The ancient cytkine IL-17D is regulated by Nrf2 and mediated tumor and virus surveillance. Cytkine 91: 10–2.
105. Liang S.C., Tan X.-Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., Fouser L.A. (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of anti-microbial peptides. J Exp Med 203: 2271–9.